Shopping Cart
- Remove All
- Your shopping cart is currently empty
Cusatuzumab (ARGX-110) is a human CD70 monoclonal antibody with enhanced antibody-dependent cytotoxic activity that blocks CD70/CD27 signaling and targets CD70-expressing LSCs, eliminating LSCs in vitro and in xenograft assays.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $209 | In Stock | |
5 mg | $469 | In Stock | |
10 mg | $673 | In Stock | |
25 mg | $987 | In Stock | |
50 mg | $1,390 | In Stock |
Description | Cusatuzumab (ARGX-110) is a human CD70 monoclonal antibody with enhanced antibody-dependent cytotoxic activity that blocks CD70/CD27 signaling and targets CD70-expressing LSCs, eliminating LSCs in vitro and in xenograft assays. |
Alias | JNJ74494550, JNJ-4550, JNJ4550, JNJ 74494550, ARGX-110, ARGX110 |
Cas No. | 1864871-20-4 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.